Form 8-K - Current report:
SEC Accession No. 0001193125-26-091447
Filing Date
2026-03-04
Accepted
2026-03-04 16:01:24
Documents
12
Period of Report
2026-03-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d88412d8k.htm   iXBRL 8-K 23132
  Complete submission text file 0001193125-26-091447.txt   136135

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vir-20260304.xsd EX-101.SCH 2840
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20260304_lab.xml EX-101.LAB 17999
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20260304_pre.xml EX-101.PRE 11257
14 EXTRACTED XBRL INSTANCE DOCUMENT d88412d8k_htm.xml XML 3630
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 26721059
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)